Is Biogen’s Research Pipeline a Reason to Invest?
Biogen Inc. (NASDAQ:BIIB) has been a laggard this year with its share price plunging 41% year-to-date against the broader market’s 26.6% gain. The …
Cohen & Steers Inc
Will Acadia Pharmaceuticals Stock Recover?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is at the forefront of neuroscience developing therapies for central nervous system conditions. The company primarily …
